Oxazepam (Epilepsy) - Medication and Pregnancy KB

Oxazepam (Epilepsy)

Exposed non-exposed, cohort studies

Study	Country Study period Study design	Data source	Exposure definition	Non-exposure definition	Exposition period	Sample size (exposed/unexposed) Or (case / control)	Remarks	Risk of bias
Mawer (Epilepsy) (Controls exposed to Lamotrigine, sick) 2010	United Kingdom 2000 - 2006 prospective cohort	11 National Health Service (NHS) hospitals within Merseyside and Greater Manchester, United Kingdom.	Children born to mothers with epilepsy exposed to oxazepam monotherapy in utero. (This is a subgroup of exposure among the whole exposed group considered in the study).	exposed to other treatment, sick Children born to mothers with epilepsy exposed to lamotrigine monotherapy in utero.	1st trimester	1 / 40	Period of exposure confirm by author's email.
	United Kingdom 2000 - 2006 prospective cohort		The research nurse recorded personal and medical history with forms. An epilepsy specialist confirmed antiepileptic medication. Information from the patient was supplemented from clinical records.		1st trimester	1 / 40	Period of exposure confirm by author's email.
Mawer (Epilepsy) (Controls unexposed, disease free) 2010	United Kingdom 2000 - 2006 prospective cohort	11 National Health Service (NHS) hospitals within Merseyside and Greater Manchester, United Kingdom.	Children born to mothers with epilepsy exposed to oxazepam monotherapy in utero. (This is a subgroup of exposure among the whole exposed group considered in the study).	unexposed, disease free Children born to mothers without epilepsy who attended the same clinic on the same day or a few days later.	1st trimester	1 / 315	Period of exposure confirm by author's email.
Mawer (Epilepsy) (Controls unexposed, disease free) 2010	United Kingdom 2000 - 2006 prospective cohort		The research nurse recorded personal and medical history with forms. An epilepsy specialist confirmed antiepileptic medication. Information from the patient was supplemented from clinical records.		1st trimester	1 / 315	Period of exposure confirm by author's email.
Mawer (Epilepsy) (Controls unexposed, sick) 2010	United Kingdom 2000 - 2006 prospective cohort	11 National Health Service (NHS) hospitals within Merseyside and Greater Manchester, United Kingdom.	Children born to mothers with epilepsy exposed to oxazepam monotherapy in utero. (This is a subgroup of exposure among the whole exposed group considered in the study).	unexposed, sick Children born to women with untreated epilepsy, who took no antiepileptic drugs before or during pregnancy.	1st trimester	1 / 46	Period of exposure confirm by author's email.
Mawer (Epilepsy) (Controls unexposed, sick) 2010	United Kingdom 2000 - 2006 prospective cohort		The research nurse recorded personal and medical history with forms. An epilepsy specialist confirmed antiepileptic medication. Information from the patient was supplemented from clinical records.		1st trimester	1 / 46	Period of exposure confirm by author's email.

Case-control studies

Study	Country Study period Study design	Data source	Case	Control	Exposition	Exposition period	Sample size (exposed/unexposed) Or (case / control)	Remarks	Risk of bias

Risk of bias: : NA; : low; : moderate; : serious; : critical; : unclear;

Empty. There are no case-control studies available for this drug.

master protocol